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A B S T R A C T
Primary adult Ewing’s sarcoma is a rare entity. They most commonly occur in children and young adults. 6% of them
are localized extraosseously. We present a case of a 51 year old patient with primary renal Ewing’s sarcoma and multiple
metastases in liver and iliac bone. Patients with metastatic disease are usually treated with aggressive chemotherapy
and have a poor outcome. Our patient underwent complete surgical excision of tumour, and was treated with aggressive
chemotherapy, respectively. Two and half years after presentation he is well, without any symptoms.
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Introduction
Ewing’s family of tumours includes Ewing’s sarcoma
of bone, extraosseous Ewing’s sarcoma, and primitive
neuro-ectodermal tumour (PNET). It primarily arises in
bones, most commonly in children and young adults.
They are extraosseous in approximately 6% of cases. The
most common sites of extraosseous Ewing’s sarcomas are
the trunk, extremity, head and neck, and retroperito-
neum1,2. Ewing’s sarcoma of primary renal origin is a
rare entity in the adult population and often has an ag-
gressive course3,4. According to the WHO, 2004 (Tu-
mours of the urinary system and male genital organs) 35
cases of renal PNET/EWS were recorded. The mean age
of presentation was 27 years with predilection for males
(21 males, 14 females). The principles of management of
extraskeletal Ewing’s tumour have been extrapolated
from the experience of treating osseous Ewing’s sarcoma
or from high grade sarcomas of the same site and stage,
though some studies have suggested that extraosseous
Ewing’s sarcoma may have poorer prognosis2,6. Litera-
ture regarding primary renal Ewing’s sarcoma in adults
is limited to case reports or short case series. No definite
recommendations regarding optimal treatment have been
defined5–8.
A single institution experience of the clinical presen-
tation, management and outcome of this rare tumour is
presented here.
Clinical History
A 51 year old man was admitted to our hospital with
severe and persistent pain in the right leg over the last
two month. On physical examination impossibility for
plantar and dorsal flexion of the foot was detected. His
past medical history was almost unremarkable except for
cerebral meningeoma which was surgically resected 6
years ago with two recurrences after 2 and 3 years. Ul-
trasound examination and abdominal computer tomog-
raphy (CT) revealed expansive tumour of the right kid-
ney extending to and compressing psoas muscle. In the
second segment of the left liver lobe, metastatic tumour
mass was also found. Right wing of the iliac bone was in-
filtrated with expansive tumour mass.
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Materials and Methods
A fine needle aspiration biopsy (FNAB) of the iliacal
tumour mass was performed, stained with May-Grun-
wald-Giemsa (MGG) and revealed poorly differentiated
malignant cells, with some cytoplasms displaying dis-
crete vacuolization and nuclei with coarse chromatin
structure (Figure 1). Most of them had degenerative
changes. A lot of naked oval and ovoid malignant nuclei
were also seen. Immunocytochemical analysis revealed
weak and nonspecific positivity for EMA and vimentin. It
was diagnosed as metastatic epithelial tumour, of the
possible renal origin.
Radical tumourectomy was performed with complete
resection of the right kidney, right liver lobe (2. and 3.
segment) and complete resection of the iliacal tumour
mass (Figure 2 and 3). Intrasurgical exploration of the
liver detected 2 more metastases in the 4b. and 5. seg-
ment. On a cross section of the right kidney which
measurred 14:8:4 cm, in the upper pole, a circumscribed,
yellow-greyish tumour with areas of haemorrhage, mea-
surring 5:5.5:3.7 cm was found. In the middle part of the
kidney another tumour with identical gross characteris-
tics as the previuosly described one, was also found. It
measurred 2:2: 1.5 cm. Both tumours neither invaded
pelvis nor blood vessels. Microscopic examination of the
excised specimen showed sheets, islands and lobules of
uniform cells with round nuclei, dispersed chromatin
pattern and prominent nucleoli (Figure 4). The immuno-
histochemical analysis revealed vimentin, CD99 (Figure
5) and NSE (Figure 6) positivity. Three metastases mea-
suring 8 cm, 8 and 7 mm were found in the resected liver
segments. Iliacal tumour mass measurred 14:10:3 cm.
All of them showed identical histologic picture. The clini-
cal presentation, histological pattern, cytological charac-
teristics and the cellular immunophenotype addressed
the diagnosis towards Ewing's sarcoma (by F. Kne`evi}).
Ewing’s sarcoma has been confirmed using reverse tran-
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Fig. 1. Cytological analysis detected accumulations of poorly dif-
ferentiated malignant cells with coarse chromatin structure in
nuclei.
Fig. 2. Complete resection of the right kidney which measurred
14:8:4 cm.
Fig. 3. Liver metastasis measurring 8 cm.
Fig. 4. The tumour is composed of uniform cells with round nu-
clei, dispersed chromatin pattern and prominent nucleoli. Tu-
mour cells form sheets, islands and lobules.
scription PCR analysis where tumour specific translo-
catation t(11:22) and fusion gene EWS/ FLI-1 was found.
The patient recieved 6 cycles of chemotherapy in the
last two years according to the VAIA protocol which in-
cluded Uromitexan (4600 mg i.v. u 1000 ml fiz.ot/24h),
Vinkristin (2 mg i.v.), Holoxan (3650 mg i.v. u 1000 ml fiz
ot/24h), Kytril (1 amp i.v.) Daktinomicin (0.9 mg i.v.).
The patient is well, without any symptoms two and half
years after the operation.
Discussion
Ewing’s sarcoma (EWS)/ peripheral primitive neuro-
ektodermal tumour (PNET) and small round cell tu-
mours occurring in bone and soft tissues characterised as
a group by the presence of the typical translocation
t(11;22) (q24;q12)and its variants9. A total of approxi-
mately 65 primary renal cases have been reported to
date10. In practice, all Ewing’s family tumours are trea-
ted in the same fashion using a combination of local ther-
apy and aggressive combination chemotherapy. There is
no absolute protocol or treatment for Ewing/PNET ow-
ing to its rarity. The prognosis is poor with a 5 year dis-
ease free survival rate of about 50% despite multimodal
therapy.
A retrospective study was conducted at the Royal
Marsden Hospital from January 1993-December 200711.
The study included 7 patients (range 25–57 years, both
sexes) 4 of them with nonmetastatic disease and 3 with
metastatic disease at presentation. They were all treated
with aggressive chemotherapy. The median follow-up
was 36 month. None of the patients with metastatic dis-
ease at presentation had a durable response to chemo-
therapy and all had a short survival. They all died in the
interval of 1 to 5 years after the tumour was diagnosed.
The oldest patient (50 years old) had the shortest sur-
vival. It should be pointed out that none of the patients
with metastatic disease underwent radical nephrectomy.
On contrary, all of the patients with localised disease un-
derwent radical nephrectomy and received chemother-
apy. They had much better survival. Our patient, in spite
of metastatic disease, underwent radical nephrectomy
with complete excision of all the metastases, received ag-
gressive chemotherapy and is two and half years after
the presentation well and without any signs of recur-
rence. Some reports suggest that long-term survival of
patients with renal Ewing’s sarcoma could be due to
complete surgery, especially radical nephrectomy12. Our
experience confirms this hypothesis.
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Fig. 5. Immunohistochemical evaluation revealed CD99 positivity.
PRIMARNI EWINGOV SARKOM BUBREGA: PRIKAZ SLU^AJA
S A @ E T A K
Primarni Ewingov sarkom odraslih osoba je vrlo rijedak. Naj~e{}e se pojavlju u dje~joj i mla|oj adolescentnoj dobi.
6% ih je smje{teno izvan kostiju. Prikazujemo slu~aj 51 godi{njeg bolesnika sa primarnim Ewingovim sarkomom bubre-
ga i sa vi{e metastaza u jetri i ilija~noj kosti. Pacijenti sa metastatskom bolesti se obi~no tretiraju agresivnom kemote-
rapijom i imaju lo{u prognozu. Na{em je pacijentu kompletno kirur{ki odstranjen tumor, a tek nakon toga je bio lije~en
agresivnom kemoterapijom. 2 i pol godine nakon po~etka lije~enja, pacijent je dobro, bez ikakvih simptoma.
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